Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.7803
-0.0021 (-0.27%)
At close: Feb 27, 2026, 4:00 PM EST
0.8200
+0.0397 (5.09%)
After-hours: Feb 27, 2026, 5:15 PM EST
Aptorum Group Revenue
Aptorum Group had revenue of $199.76K in the half year ending August 31, 2025.
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
6.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 431.38K | -864.51K | -66.71% |
| Dec 31, 2022 | 1.30M | -245.89K | -15.95% |
| Dec 31, 2021 | 1.54M | 630.27K | 69.15% |
| Dec 31, 2020 | 911.51K | 376.34K | 70.32% |
| Dec 31, 2019 | 535.17K | 151.72K | 39.57% |
| Dec 31, 2018 | 383.45K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Immuron | 4.99M |
| Xenetic Biosciences | 2.86M |
| XTL Biopharmaceuticals | 968.00K |
| Can-Fite BioPharma | 560.00K |
| Aprea Therapeutics | 488.24K |
| Creative Medical Technology Holdings | 6.00K |
APM News
- 26 days ago - Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease - GlobeNewsWire
- 3 months ago - DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference - GlobeNewsWire
- 3 months ago - Andean Precious Metals Corp. (APM:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering - GlobeNewsWire
- 5 months ago - As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives - GlobeNewsWire
- 6 months ago - Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 months ago - Why Is Nano-Cap Aptorum Stock Rallying On Thursday? - Benzinga
- 6 months ago - DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR's APOE Genotyping Test - GlobeNewsWire